S

Sanbo Hospital Management Group Ltd
SZSE:301293

Watchlist Manager
Sanbo Hospital Management Group Ltd
SZSE:301293
Watchlist
Price: 47.86 CNY -0.5% Market Closed
Market Cap: 9.9B CNY
Have any thoughts about
Sanbo Hospital Management Group Ltd?
Write Note
Sanbo Hospital Management Group Ltd
/
Balance Sheet
/
Cash & Cash Equivalents

Sanbo Hospital Management Group Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sanbo Hospital Management Group Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cash & Cash Equivalents
¥822.1m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Cash & Cash Equivalents
¥853.8m
CAGR 3-Years
30%
CAGR 5-Years
35%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cash & Cash Equivalents
¥5.5B
CAGR 3-Years
5%
CAGR 5-Years
26%
CAGR 10-Years
24%
Hengkang Medical Group Co Ltd
SZSE:002219
Cash & Cash Equivalents
¥449.3m
CAGR 3-Years
28%
CAGR 5-Years
22%
CAGR 10-Years
12%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cash & Cash Equivalents
¥667.3m
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cash & Cash Equivalents
¥3.9B
CAGR 3-Years
98%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sanbo Hospital Management Group Ltd
Glance View

Market Cap
9.9B CNY
Industry
Health Care

Sanbo Hospital Management Group Ltd., rooted in the bustling heart of China's healthcare sector, stands as a beacon of modern medical management and innovation. Founded with the mission to address the ever-growing healthcare demands of an expanding urban population, Sanbo has adeptly navigated the complexities of the industry through its impressive network of specialized hospitals and clinics. This enterprise thrives by streamlining hospital operations and fostering an environment where cutting-edge technologies meet compassionate care. By focusing primarily on neurology, a field with increasing incidence and demand globally, Sanbo captures a niche market. Its approach showcases a blend of expertise, employing skilled medical professionals coupled with state-of-the-art medical facilities, thereby enhancing the quality of patient outcomes and drawing a steady stream of clientele. The company's revenue engine hums efficiently by scaling its specialized services and implementing a multi-layered service model. Sanbo generates income through various channels, including direct patient care, diagnostic services, surgical treatments, and long-term patient management programs. Additionally, the firm harnesses strategic partnerships and collaborations with both public and private sectors to expand its reach and improve healthcare accessibility. A notable portion of its revenue also emanates from offering consultancy services to lesser-equipped hospitals looking to optimize their operations. By spearheading initiatives in research and development, Sanbo not only broadens its expertise but also attracts intellectual capital and investments. Each layer of its operations synergistically works to strengthen its foothold in the healthcare market, creating a sustainable model that continues to thrive amidst the evolving medical landscape.

Intrinsic Value
24.92 CNY
Overvaluation 48%
Intrinsic Value
Price
S
What is Intrinsic Value?

See Also

What is Sanbo Hospital Management Group Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
822.1m CNY

Based on the financial report for Dec 31, 2023, Sanbo Hospital Management Group Ltd's Cash & Cash Equivalents amounts to 822.1m CNY.

What is Sanbo Hospital Management Group Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
16%

Over the last year, the Cash & Cash Equivalents growth was 43%. The average annual Cash & Cash Equivalents growth rates for Sanbo Hospital Management Group Ltd have been 16% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.